Home
Conditions
Vector Borne Diseases

Clinical trial condition

Vector Borne Diseases

Explore clinical trials studying Vector Borne Diseases. Study availability and eligibility vary by location and protocol.

2,038 public trials 145 recruiting studies

Refine in advanced search Browse all conditions

Vector Borne Diseases trial results

Completed

Malaria Challenge With NF54 Strain

NCT00744133

Conditions: Infections, Malaria, Malaria, Falciparum, +5 more
Locations: University of Maryland School of Medicine - Center for Vaccine Development - Baltimore Baltimore, Maryland, United States

View Trial Details

Completed

Study of Pharmacokinetics and Pharmacodynamics of Artesunate in Pregnant Women in the Democratic Republic of Congo

NCT00538382

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: Kingasani Maternity Clinic Kinshasa, Democratic Republic of the Congo

View Trial Details

Completed

Safe Pregnancy by Infectious Disease Control

NCT00489619

Conditions: Communicable Diseases, Disease Attributes, Genital Diseases, +11 more
Locations: Binza Maternity Kinshasa, Democratic Republic of the Congo

Kingasani Maternity Kinshasa, Democratic Republic of the Congo

View Trial Details

Completed

Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51

NCT00596102

Conditions: Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +17 more
Locations: Not specified

View Trial Details

Completed

Molecular Assessment of Artemisinin Resistance Markers in Eastern and Western Border Areas of Myanmar

NCT02198573

Conditions: Day-3 Positive of Parasitaemia, Infections, Malaria, +5 more
Locations: Dr. Myat Phone Kyaw Yangon, Burma

View Trial Details

Completed

Phase 3 Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia)

NCT00606580

Conditions: Cutaneous Leishmaniasis, Euglenozoa Infections, Infections, +9 more
Locations: Central Clinic-Sidi Bouzid Tunis, Tunisia

View Trial Details

Completed

Azithromycin Plus Chloroquine Versus Artemether-Lumefantrine For The Treatment Of Uncomplicated P. Falciparum Malaria In Children In Africa

NCT00677833

Conditions: Infections, Malaria, Malaria, Falciparum, +4 more
Locations: Pfizer Investigational Site Nouna, Burkina Faso

Pfizer Investigational Site Ouagadougou, Burkina Faso

Pfizer Investigational Site Abidjan, Côte d’Ivoire

Pfizer Investigational Site Navrongo, Ghana

View Trial Details

Completed

A Three Day Trial of Azithromycin Plus Chloroquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria

NCT00282919

Conditions: Falciparum Malaria, Infections, Malaria, +5 more
Locations: Pfizer Investigational Site Tumaco, Departamento de Nariño, Colombia

Pfizer Investigational Site Bambolim, Goa, India

View Trial Details

Completed

In Vivo Efficacy of Artemether-lumefantrine and Amodiaquine-artesunate in Mozambican Children

NCT02168569

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: Hospital Rural de Montepuez Montepuez, Cabo Delgado Province, Mozambique

Hospital Rural de Chókwe, Chokwé, Gaza Province, Mozambique

Centro de Investigação em Saúde de Manhiça Manhiça, Maputo Province, Mozambique

Centro de Saúde de Dondo Dondo, Sofala, Mozambique

View Trial Details

Completed

Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina Faso

NCT01018459

Conditions: Infections, Malaria, Mosquito-Borne Diseases, +3 more
Locations: Centre National de Recherche et de Formation sur le Paludisme - Research and Training West Africa, Burkina Faso

View Trial Details

Vector Borne Diseases

Vector Borne Diseases trial results

Related conditions